Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Biochemistry-based machine learning algorithms in differentiating pleural effusion: current status and perspective.

Created on 28 Jul 2026

Authors

Wen-Jie Hou, Xu-Lei Hao, Ran-Tong Bao, Li Yan, José M Porcel, Wen-Qi Zheng, Ya-Nan Xu, Zhi-De Hu

Published in

ERJ open research. Volume 12. Issue 4. Epub Jul 27, 2026.

Abstract

The differential diagnosis of pleural effusion remains challenging. Microbiological and cytopathological examinations are considered the gold standards; however, they are limited by their low sensitivity, subjectivity, invasiveness and prolonged turnaround times. Pleural fluid and serum biochemical tests offer the advantages of objectivity, short turnaround time, minimal invasiveness and easy accessibility, which can help pulmonologists estimate the risk of the target disease. However, their effectiveness is often suboptimal when they are used alone. Recent advances suggest that machine learning (ML) algorithms can enhance diagnostic accuracy when combined with multiple parameters. Several studies have applied ML approaches based on biochemical tests to diagnose pleural effusion, with preliminary results indicating an improved diagnostic performance. This article reviews the application of such algorithms in the differential diagnosis of pleural effusion, highlights their current limitations and provides recommendations for future research.

PMID:
42516904
Bibliographic data and abstract were imported from PubMed on 28 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement